| Autor: |
Vrandecic, Mario Osvaldo P., Fantini, Fernando A., Gontijo, Bayard F., Oliveira, Ozanam C., Martins, Idail C.J., Oliveira, Marcelo H.C., Avelar, Sandra O.S., Vrandecic, Erika, Vrandecic, Ektor |
| Zdroj: |
The Annals of Thoracic Surgery; August 1995, Vol. 60 Issue: 1, Number 1 Supplement 2 pS439-S442, 4p |
| Abstrakt: |
The new stentless porcine mitral valve was developed to serve as an anatomically correct substitute for a diseased mitral valve. Extensive acute animal experimentation was performed, and from this the logical sequence for selecting the correct valve size and the specific technique for implanting it were determined. The following are the major steps to successfully implant a mitral stentless valve: First, mitral valve complex analysis must be done to determine the correct procedure to be performed and the feasibility of using the stentless mitral valve. Second, the correct size of stentless mitral valve must be chosen. Third, the papillary muscle anatomy must be assessed to determine the site and number of sutures necessary for securely holding the new origin of the new chordae. Fourth, the papillary muscle sutures must be anchored to the free pericardial edge of the new chordal origin. Fifth, the chordal alignment with both trigonal areas must be perfect. Sixth, the annulus may be sutured using either continuous or interrupted sutures. Perioperative echocardiography, preferably transesophageal echocardiography, should be done in every patient. Although reoperation was necessary in 5 patients (non-valve-related), the results in 74 patients (3 early and 3 late non-valve-related deaths excluded) followed up for at most 26 months (mean, 14 months) have been excellent. The quality of the results obtained in this initial clinical trial has reinforced our current preference for this valve in patients requiring mitral valve replacement. Longer follow-up is required to confirm that these good results continue. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
